Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD (Ersa)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05454956 |
|
Recruitment Status :
Completed
First Posted : July 12, 2022
Last Update Posted : November 13, 2023
|
Sponsor:
Tarsus Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Tarsus Pharmaceuticals, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | May 18, 2023 |
| Actual Study Completion Date : | May 18, 2023 |